Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. Cancers 2021, 13, 3814
On 2 July 2021, Kronenfeld et al. [...] View Full-Text
Notter, M.; Stutz, E.; Thomsen, A.R.; Kollár, A.; Vaupel, P. Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. Cancers 2021, 13, 3814. Cancers 2021, 13, 5707. https://doi.org/10.3390/cancers13225707
Notter M, Stutz E, Thomsen AR, Kollár A, Vaupel P. Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. Cancers 2021, 13, 3814. Cancers. 2021; 13(22):5707. https://doi.org/10.3390/cancers13225707
Chicago/Turabian StyleNotter, Markus, Emanuel Stutz, Andreas R. Thomsen, Attila Kollár, and Peter Vaupel. 2021. "Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. Cancers 2021, 13, 3814" Cancers 13, no. 22: 5707. https://doi.org/10.3390/cancers13225707